These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 1809995)

  • 1. [Socioeconomic aspects of rheumatoid arthritis].
    Jajić I; Jajić Z; Ozić-Bebek M; Sućur A
    Reumatizam; 1991; 38(1-4):7-11. PubMed ID: 1809995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
    Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
    Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists.
    Guillemin F; Durieux S; Daurès JP; Lafuma A; Saraux A; Sibilia J; Bourgeois P; Sany J
    J Rheumatol; 2004 Jul; 31(7):1297-304. PubMed ID: 15229947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of cardiovascular illness on hospitalization costs in patients with rheumatoid arthritis].
    Pineda-Tamayo R; Arcila G; Restrepo P; Anaya JM
    Biomedica; 2004 Dec; 24(4):366-74. PubMed ID: 15678800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?
    Gabriel SE; Wagner JL; Zinsmeister AR; Scott CG; Luthra HS
    Arthritis Rheum; 2001 Jul; 44(7):1504-14. PubMed ID: 11465700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls.
    Gabriel SE; Crowson CS; Campion ME; O'Fallon WM
    J Rheumatol; 1997 Jan; 24(1):43-8. PubMed ID: 9002009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
    Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
    Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand.
    Osiri M; Maetzel A; Tugwell P
    J Rheumatol; 2007 Jan; 34(1):57-63. PubMed ID: 17183621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).
    Hallert E; Husberg M; Jonsson D; Skogh T
    Rheumatology (Oxford); 2004 Nov; 43(11):1374-82. PubMed ID: 15280570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
    Michaud K; Messer J; Choi HK; Wolfe F
    Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of oral valdecoxib versus diclofenac in the treatment of patients with rheumatoid arthritis in a randomized clinical trial.
    von Scheele B; Peña B; Wong J; Niculescu L
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii53-9. PubMed ID: 14585918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study.
    Lajas C; Abasolo L; Bellajdel B; Hernández-García C; Carmona L; Vargas E; Lázaro P; Jover JA
    Arthritis Rheum; 2003 Feb; 49(1):64-70. PubMed ID: 12579595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoeconomic study of patients with chronic inflammatory joint disease before and during infliximab treatment.
    Laas K; Peltomaa R; Kautiainen H; Puolakka K; Leirisalo-Repo M
    Ann Rheum Dis; 2006 Jul; 65(7):924-8. PubMed ID: 16339293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Newhall-Perry K; Law NJ; Ramos B; Sterz M; Wong WK; Bulpitt KJ; Park G; Lee M; Clements P; Paulus HE
    J Rheumatol; 2000 May; 27(5):1156-63. PubMed ID: 10813281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rheumatoid arthritis care costs in patients starting therapy with leflunomide versus etanercept.
    Yazdani C; McLaughlin T; Cummins G; Doyle J
    Am J Manag Care; 2001 Sep; 7(13 Suppl):S419-26. PubMed ID: 11594238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it possible to identify early predictors of the future cost of chronic arthritis? The VErA project.
    Flipon E; Brazier M; Clavel G; Boumier P; Gayet A; Le Loët X; Fardellone P;
    Fundam Clin Pharmacol; 2009 Feb; 23(1):105-13. PubMed ID: 19267774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter study of hospitalization in rheumatoid arthritis: effect of health care system, severity, and regional difference.
    Wolfe F; Kleinheksel SM; Spitz PW; Lubeck DP; Fries JF; Young DY; Mitchell DM; Roth SH
    J Rheumatol; 1986 Apr; 13(2):277-84. PubMed ID: 3723493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis.
    van den Hout WB; Goekoop-Ruiterman YP; Allaart CF; de Vries-Bouwstra JK; Hazes JM; Kerstens PJ; van Zeben D; Hulsmans HM; de Jonge-Bok JM; de Sonnaville PB; Dijkmans BA; Breedveld FC
    Arthritis Rheum; 2009 Mar; 61(3):291-9. PubMed ID: 19248130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct medical costs unique to people with arthritis.
    Gabriel SE; Crowson CS; Campion ME; O'Fallon WM
    J Rheumatol; 1997 Apr; 24(4):719-25. PubMed ID: 9101508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.